Lithuanian Life Sciences Industry

Life Sciences Industry is one of the fastest-growing industrial sectors in Lithuania and one of the most advanced industries in Central and Eastern Europe!


  • World-recognized competencies in molecular biology, biophysics, genetics, biomedicine and enzymology
  • Established solid research and experimental infrastructure
  • Talented professionals
  • Favorable economic environment, good business conditions
  • Attractive tax system
  • Well-organised logistics
  • Advanced information and communication technologies



The achievements of Lithuanian scientists in the field of life sciences are already recognized worldwide:

  • KTU professor Arminas Ragauskas, author of more than 140 inventions and patents in US, EU and Japanese, received the U.S. Congress of Neurosurgeon Award for best scientific article of 2017. The non-invasive technology for physiological measurement and monitoring of human brain injuries, developed by the professor and the researchers under his leadership, promises a revolution in the medicine of brain injuries.
  • VU Professor Virginijus Šikšnys became a laureate of the prestigious Kavli Prize in 2018 for the discovery of CRISPR-Cas9 or the so-called “gene scissors”. He paved the way for new genome editing tools. The professor developed and licensed Cas9 technology for an international company and was one of the candidates for the Nobel Prize.
  • Urtė Neniškytė, a neuroscientist and doctor of biochemistry at the VU Life Sciences Center, leads a group of researchers studying the interaction of neurons and immune cells in the brain. The researcherhas  received the UNESCO Science for Women International Emerging Talent Award, and was selected for Marie Skłodowska-Curie and L’Oreal-UNESCO Science for Women Scholarships.
  • The author of articles in prestigious scientific journals biophysicist Professor Daumantas Matulis and his team have developed a molecule that can be used for anticancer drugs. The professor, who has been awarded international awards in Italy, Finland and Sweden, also owns several patented inventions and won the Lithuanian Science Prize in 2012.



  • In the issue of the U.S. scientific journal Scientific American Worldview, Lithuania ranked 16th position out of 54 countries in the assessment of innovative potential in the field of biotechnology in 2018. Lithuania has risen 18 positions in the last 5 years: from 34th to 16th!
  • In 2019 Lithuania ranks 38th position among 129 countries in the world on the Global Innovation Index rating scale which is published by the World Intellectual Property Organisation. According to 4 indicators, Lithuania is among the top ten countries.
  • In the Forbes business magazine, Lithuania was ranked 27th out of 161 countries in the ranking of business-friendly countries of 2019.
  • Lithuania ranks 39th out of 141 ranked states in the 2019 Global Competitiveness Report which is annually held in the World Economic Forum.
  • According to country assessment based on the science and business sector cooperation index presented in the World Economic Forum, Lithuania ranked 1st among the countries of Central and Eastern Europe in the research and experimental development activities.
  • According to the 2018 World Bank Enterprise Survey, Lithuania ranks 14th out of 190 countries rated.


  • More than 15,000 scientists carry out life science projects.
  • More than 400 companies are active in the life sciences industry.
  • More than 5,000 persons work for companies in the life sciences industry.
  • More than 40 start-ups focus on life sciences.
  • More than 100 scientists work at JSC Thermo Fisher Scientific Baltics, the largest privately held research and development center in the Baltic region.
  • 5 Valleys (Integrated Science, Studies and Business centers) operate in Lithuania.
  • 25 OPEN R&D Open Access Centres provide Research Services.
  • Over 20 measures are aimed at promoting innovation in Lithuania.
  • 7 universities and 7 colleges have Bachelor’s degree programs in life sciences.
  • More than 10,000 students choose life sciences studies each year.
  • Vilnius University student teams have won 5 gold medals, 1 bronze and 1 grand prize at the prestigious synthetic biology iGEM Competition since 2015.
  • 90% of Lithuanian life sciences products are exported to more than 100 countries.
  • €678.9 million from EU funds is intended for the promotion of research, experimental development and innovation. €75.4 million from the above-mentioned amount is assigned for Health Technologies and Biotechnology fields.
  • Turnover of Lithuanian Life Sciences Industry Companies comprised €613.4 million in 2016. There was an average annual growth of 22.1% in 2011-2016.
  • €309.1 million is the value of goods of Lithuanian origin exported by life science companies in 2017. It accounts for 2% of the total export of goods of Lithuanian origin by Lithuanian enterprises. Compared to 2010, exports increased 3.5 times.
  • In 2016 €301 million of the gross value added was created by Lithuanian life sciences companies.
  • The nominal value-added generated by enterprises in the life sciences industry has increased 3.9 times since 2010, and its share in the gross value added of the country has almost tripled from 0.3% to 0.87%;
  • UAB Thermo Fisher Scientific Baltics paid income tax of €23,322 in 2018 and became the largest corporate taxpayer of the year. This company, together with JSC Sicor Biotech, paid more income tax than all Lithuanian banks.
  • More than €400 million has been invested in life sciences infrastructure.
  • 10% of the global scientific laser market is occupied by Lithuanian lasers*

Close colaboration of science and business, projects in collaboration with the most famous foreign scientists, universities and private enterprises, a new generation of scientists performing miracles in university laboratories contribute to the achievements of Life Sciences in Lithuania.

*The data is used from the following sources: the Department of Statistics of Lithuania,, MITA, Enterprise Lithuania, Invest in Lithuania, etc.


Last updated: 27-05-2020